1. Home
  2. UPBD vs VERA Comparison

UPBD vs VERA Comparison

Compare UPBD & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UPBD
  • VERA
  • Stock Information
  • Founded
  • UPBD 1986
  • VERA 2016
  • Country
  • UPBD United States
  • VERA United States
  • Employees
  • UPBD N/A
  • VERA N/A
  • Industry
  • UPBD Diversified Commercial Services
  • VERA Biotechnology: Pharmaceutical Preparations
  • Sector
  • UPBD Consumer Discretionary
  • VERA Health Care
  • Exchange
  • UPBD Nasdaq
  • VERA Nasdaq
  • Market Cap
  • UPBD 1.5B
  • VERA 1.4B
  • IPO Year
  • UPBD 1995
  • VERA 2021
  • Fundamental
  • Price
  • UPBD $25.02
  • VERA $23.77
  • Analyst Decision
  • UPBD Buy
  • VERA Buy
  • Analyst Count
  • UPBD 4
  • VERA 8
  • Target Price
  • UPBD $34.50
  • VERA $64.29
  • AVG Volume (30 Days)
  • UPBD 587.5K
  • VERA 1.9M
  • Earning Date
  • UPBD 10-30-2025
  • VERA 11-06-2025
  • Dividend Yield
  • UPBD 6.24%
  • VERA N/A
  • EPS Growth
  • UPBD 78.87
  • VERA N/A
  • EPS
  • UPBD 1.79
  • VERA N/A
  • Revenue
  • UPBD $4,481,986,000.00
  • VERA N/A
  • Revenue This Year
  • UPBD $9.99
  • VERA N/A
  • Revenue Next Year
  • UPBD $8.44
  • VERA N/A
  • P/E Ratio
  • UPBD $13.96
  • VERA N/A
  • Revenue Growth
  • UPBD 7.49
  • VERA N/A
  • 52 Week Low
  • UPBD $19.65
  • VERA $18.53
  • 52 Week High
  • UPBD $36.00
  • VERA $51.61
  • Technical
  • Relative Strength Index (RSI)
  • UPBD 52.91
  • VERA 55.58
  • Support Level
  • UPBD $24.39
  • VERA $23.69
  • Resistance Level
  • UPBD $25.59
  • VERA $25.29
  • Average True Range (ATR)
  • UPBD 0.65
  • VERA 1.21
  • MACD
  • UPBD -0.01
  • VERA 0.21
  • Stochastic Oscillator
  • UPBD 34.81
  • VERA 63.29

About UPBD Upbound Group Inc.

Upbound Group Inc is an omnichannel platform company committed to elevating financial opportunity for all through inclusive, and technology-driven financial solutions that address the evolving needs and aspirations of consumers. It has three operating segments; The Rent-A-Center Business segment operates lease-to-own stores, the Acima segment offers the lease-to-own transaction to consumers who do not qualify for financing from the traditional retailer, and also offers the lease-to-own transaction through virtual offering solutions across e-commerce, digital, and mobile channels, Mexico segment offers lease-to-own stores in Mexico. The franchising segment offers the sale of rental merchandise to its franchisees. The company derives a majority of its revenue from the Acima segment.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: